RNA-Mediated Reprogramming of Primary Adult Human Dermal Fibroblasts into c-kit+ Cardiac Progenitor Cells

Stem Cells and Development

Volumn 24, Issue 22, 2015, Pages 2622-2633

  Pratico, Elizabeth D ^a   Feger, Bryan J ^a   Watson, Michael J ^a   Sullenger, Bruce A ^a   Bowles, Dawn E ^a   Milano, Carmelo A ^a   Nair, Smita K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; CAFFEINE; CALCIUM; GENOMIC DNA; ISL 1 PROTEIN; MESSENGER RNA; PROTEIN; RYANODINE RECEPTOR 2; SERCA2 PROTEIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR NKX2.5; TROPONIN T; UNCLASSIFIED DRUG; ACTININ; HOMEODOMAIN PROTEIN; INSULIN GENE ENHANCER BINDING PROTEIN ISL-1; LIM HOMEODOMAIN PROTEIN; NKX2-5 PROTEIN, HUMAN; RYANODINE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CALCIUM TRANSPORT; CARDIAC STEM CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; HEART FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NEWBORN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; SKIN BIOPSY; ADULT STEM CELL; CARDIAC MUSCLE CELL; CELL LINE; CYTOLOGY; FIBROBLAST; GENETICS; METABOLISM;

ACTININ; ADULT STEM CELLS; CELL LINE; CELLULAR REPROGRAMMING; FIBROBLASTS; HOMEODOMAIN PROTEINS; HUMANS; LIM-HOMEODOMAIN PROTEINS; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-KIT; RNA, MESSENGER; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TRANSCRIPTION FACTORS; TROPONIN T;

EID: 84947087360     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2015.0073     Document Type: Article

References (52)

1. Garbern Jessica C and T Lee Richard. (2013). Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell 12:689-698.
2. Doppler SA, M-A Deutsch, R Lange and M Krane. (2013). Cardiac regeneration: current therapies-future concepts. J Thorac Dis 5:683-697.
3. Laflamme MA, KY Chen, AV Naumova, V Muskheli, JA Fugate, et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotech 25:1015-1024.
4. Nelson TJ, A Martinez-Fernandez, S Yamada, C Perez-Terzic, Y Ikeda, et al. (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120:408-416.
5. Amado LC, AP Saliaris, KH Schuleri, St. M John, J-S Xie, et al. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102:11474-11479.
6. Karantalis V and JM Hare. (2015). Use of mesenchymal stem cells for therapy of cardiac disease. Circ Res 116: 1413-1430.
7. Smith RR, L Barile, HC Cho, MK Leppo, JM Hare, et al. (2007). Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115:896-908.
8. Bearzi C, M Rota, T Hosoda, J Tillmanns, A Nascimbene, et al. (2007). Human cardiac stem cells. Proc Natl Acad Sci U S A 104:14068-14073.
9. Mishra R, K Vijayan, EJ Colletti, DA Harrington, TS Matthiesen, et al. (2011). Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation 123:364-373.
10. Hare JM. (2015). Where are we with cardiac cell-based repair for human heart failure? 18th Annual Meeting of American Society of Gene and Cell Therapy. New Orleans, LA, p 64.
11. Grens K. (2015). Hearts on Trial. The Scientist. LabX Media Group, Midland Ontario, Canada.
12. Fu JD, NR Stone, L Liu, CI Spencer, L Qian, et al. (2013). Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state. Stem Cell Reports 1: 235-247.
13. Nam YJ, K Song, X Luo, E Daniel, K Lambeth, et al. (2013). Reprogramming of human fibroblasts toward a cardiac fate. Proc Natl Acad Sci U S A 110:5588-5593.
14. Mandal PK and DJ Rossi. (2013). Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat Protoc 8:568-582.
15. Warren L, PD Manos, T Ahfeldt, YH Loh, H Li, et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7:618-630.
16. Kim TK, JY Sul, NB Peternko, JH Lee, M Lee, et al. (2011). Transcriptome transfer provides a model for understanding the phenotype of cardiomyocytes. Proc Natl Acad Sci U S A 108:11918-11923.
17. Xie M, N Cao and S Ding. (2014). Small molecules for cell reprogramming and heart repair: progress and perspective. ACS Chem Biol 9:34-44.
18. Smits AM, AA van Oorschot and MJ Goumans. (2012). Isolation and differentiation of human cardiomyocyte progenitor cells into cardiomyocytes. Methods Mol Biol 879: 339-349.
19. Kubo H, N Jaleel, A Kumarapeli, RM Berretta, G Bratinov, et al. (2008). Increased cardiac myocyte progenitors in failing human hearts. Circulation 118:649-657.
20. Lee J, D Boczkowski and S Nair. (2013). Programming human dendritic cells with mRNA. Methods Mol Biol 969: 111-125.
21. Lee J, D Boczkowski and S Nair. (2013). Engineering B cells with mRNA. Methods Mol Biol 969:101-110.
22. Smits AM, P van Vliet, CH Metz, T Korfage, JP Sluijter, et al. (2009). Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat Protoc 4:232-243.
23. Chomczynski P and K Mackey. (1995). Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide-and proteoglycanrich sources. Biotechniques 19:942-945.
24. Kubo H, RM Berretta, N Jaleel, D Angert and SR Houser. (2009). c-Kit+ bone marrow stem cells differentiate into functional cardiac myocytes. Clin Transl Sci 2:26-32.
25. Monteith GR and GSJ Bird. (2005). Techniques: highthroughput measurement of intracellular Ca2+-back to basics. Trends Pharmacol Sci 26:218-223.
26. Heusinkveld HJ and RHS Westerink. (2011). Caveats and limitations of plate reader-based high-throughput kinetic measurements of intracellular calcium levels. Toxicol Appl Pharmacol 255:1-8.
27. Song K, YJ Nam, X Luo, X Qi, W Tan, et al. (2012). Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485:599-604.
28. Drews K, G Tavernier, J Demeester, H Lehrach, SC De Smedt, et al. (2012). The cytotoxic and immunogenic hurdles associated with non-viral mRNA-mediated reprogramming of human fibroblasts. Biomaterials 33:4059-4068.
29. Khalil IA, K Kogure, H Akita and H Harashima. (2006). Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev 58:32-45.
30. Janowski E, M Berrios, L Cleemann and M Morad. (2010). Developmental aspects of cardiac Ca(2+) signaling: interplay between RyR-and IP(3)R-gated Ca(2+) stores. Am J Physiol Heart Circ Physiol 298:H1939-H1950.
31. Chen F, S Ding, BS Lee and GT Wetzel. (2000). Sarcoplasmic reticulum Ca(2+)ATPase and cell contraction in developing rabbit heart. J Mol Cell Cardiol 32:745-755.
32. Ieda M, JD Fu, P Delgado-Olguin, V Vedantham, Y Hayashi, et al. (2010). Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142:375-386.
33. Qian L, Y Huang, CI Spencer, A Foley, V Vedantham, et al. (2012). In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485:593-598
34. Maioli M, S Rinaldi, S Santaniello, A Castagna, G Pigliaru, et al. (2012). Radiofrequency energy loop primes cardiac, neuronal, and skeletal muscle differentiation in mouse embryonic stem cells: a new tool for improving tissue regeneration. Cell Transplant 21:1225-1233
35. Maioli M, S Rinaldi, S Santaniello, A Castagna, G Pigliaru, et al. (2012). Radiofrequency energy loop primes cardiac, neuronal, and skeletal muscle differentiation in mouse embryonic stem cells: a new tool for improving tissue regeneration. Cell Transplant 21:1225-1233.
36. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872
37. Boissel L, M Betancur, W Lu, WS Wels, T Marino, et al. (2012). Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens. Leuk Lymphoma 53: 958-965
38. Boissel L, M Betancur, W Lu, WS Wels, T Marino, et al. (2012). Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens. Leuk Lymphoma 53: 958-965.
39. Djurovic S, N Iversen, S Jeansson, F Hoover and G Christensen. (2004). Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes. Mol Biotechnol 28:21-32.
40. Angel M and MF Yanik. (2010). Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One 5:e11756.
41. Newton K and VM Dixit. (2012). Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 4: pii: a006049.
42. Lee J, N Sayed, A Hunter, F Au Kin, H Wong Wing, et al. (2012). Activation of innate immunity is required for efficient nuclear reprogramming. Cell 151:547-558.
43. Bhise NS, KJ Wahlin, DJ Zack and JJ Green. (2013). Evaluating the potential of poly(beta-amino ester) nanoparticles for reprogramming human fibroblasts to become induced pluripotent stem cells. Int J Nanomed 8:4641-4658.
44. Krejci E, B Dvorankova, A Kvasilova, J Borsky, M Grim, et al. (2014). Cellular and molecular characteristics of neonatal skin: consequences for healing (734.10). FASEB J 28.
45. Goumans MJ, TP de Boer, AM Smits, LW van Laake, P van Vliet, et al. (2007). TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res 1:138-149.
46. Raynaud CM, N Halabi, DA Elliott, J Pasquier, AG Elefanty, et al. (2013). Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes. PLoS One 8:e54524.
47. Gersh BJ, RD Simari, A Behfar, CM Terzic and A Terzic. (2009). Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc 84:876-892.
48. van Berlo JH, O Kanisicak, M Maillet, RJ Vagnozzi, J Karch, et al. (2014). c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 509:337-341.
49. Bolli R, AR Chugh, D D'Amario, JH Loughran, MF Stoddard, et al. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378:1847-1857.
50. Keith MC and R Bolli. (2015). "String theory" of ckit( pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results. Circ Res 116:1216-1230.
51. Wu SM, Y Fujiwara, SM Cibulsky, DE Clapham, CL Lien, et al. (2006). Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127:1137-1150.
52. Boyle AJ, SP Schulman and JM Hare. (2006). Stem cell therapy for cardiac repair: ready for the next step. Circulation 114:339-352.